CircRNA Uxs1/miR-335-5p/PGF axis regulates choroidal neovascularization via the mTOR/p70 S6k pathway
Translational Research · 2023
DOI: 10.1016/j.trsl.2023.01.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2023. Verfasst von Jiali Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Ophthalmolo…. Hauptthemen laut MEDLINE: Wet Macular Degeneration, MicroRNAs, Choroidal Neovascularization. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Shanghai Hospital Development Center, National Natural Science Foundation of China.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the elderly population. Neovascular AMD is the late stage, characterized by choroidal neovascularization (CNV). Non-coding RNAs have been implicated in CNV; however, the role of circular RNAs (circRNAs) has not yet been elucidated. Herein, we comprehensively investigated circRNA profiles in laser-induced CNV mouse models and patient specimens. A novel circRNA, circRNA Uxs1, was identified, and its function in CNV regulation was investigated in the present study. CircRNA Uxs1 was consistently upregulated in CNV patient specimens and CNV mouse models. Knockdown of circRNA Uxs1 interrupted the tube formation, migration, and proliferation of endothelial cells in vitro. Silencing circRNA Uxs1 in vivo alleviated neovascularization formation, as shown by the decreased size of laser spots. Mechanistically, circRNA Uxs1 functioned by binding to miR-335-5p, which further upregulated the expression of placental growth factor (PGF) gene and activated the mammalian target of rapamycin/p70 S6 Kinase (mTOR/p70 S6k) pathway. By subretinal injections of adeno-associated virus (AAV), we demonstrated the anti-angiogenic function of circRNA Uxs1 knockdown in vivo. In conclusion, circRNA Uxs1 promoted CNV by sponging miR-335-5p, which stimulated PGF expression and subsequently activated the mTOR/p70 S6k pathway. Therefore, circRNA Uxs1 may serve as a promising therapeutic target for CNV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Ophthalmology, Shanghai General Hospital, National Clinical Research Center for O…
- Eye Institute, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Förderung
- Shanghai Hospital Development Center
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Chen, J., Hu, J., Yao, M., Zhang, M., Wan, X., Jia, H., Wang, F., & Sun, X. (2023). CircRNA Uxs1/miR-335-5p/PGF axis regulates choroidal neovascularization via the mTOR/p70 S6k pathway. Translational Research. https://doi.org/10.1016/j.trsl.2023.01.003
Vancouver
Wu J, Chen J, Hu J, Yao M, Zhang M, Wan X, et al. CircRNA Uxs1/miR-335-5p/PGF axis regulates choroidal neovascularization via the mTOR/p70 S6k pathway. Translational Research. 2023. doi:10.1016/j.trsl.2023.01.003
BibTeX
@article{Wu2023,
author = {Wu, Jiali and Chen, Jieqiong and Hu, Jing and Yao, Mudi and Zhang, Min and Wan, Xiaoling and Jia, Huixun and Wang, Fenghua and Sun, Xiaodong},
title = {CircRNA Uxs1/miR-335-5p/PGF axis regulates choroidal neovascularization via the mTOR/p70 S6k pathway},
journal = {Translational Research},
year = {2023},
doi = {10.1016/j.trsl.2023.01.003}
}
EUVIMED